RT Book, Section A1 Bajwa, Zahid H. A1 Ho, Charles A2 Warfield, Carol A. A2 Bajwa, Zahid H. SR Print(0) ID 3419936 T1 Chapter 64. Antiepileptics for Pain T2 Principles & Practice of Pain Medicine, 2e YR 2004 FD 2004 PB The McGraw-Hill Companies PP New York, NY SN 9780071443494 LK accessanesthesiology.mhmedical.com/content.aspx?aid=3419936 RD 2024/03/29 AB Antiepileptic drugs (AEDs) have been used in the treatment of chronic pain syndromes for more than 50 years.1–4 Phenytoin, in particular, has been extensively used for the treatment of neuropathic pain during that time.5–9 Carbamazepine was the first AED used and extensively studied specifically for the treatment of trigeminal neuralgia.10–12 Since then a variety of neuropathic syndromes have been treated with AEDs, including diabetic neuropathy, postherpetic neuralgia, glossopharyngeal neuralgia, post-sympathectomy neuralgia, and post-thoracotomy pain syndromes.1–4 The AEDs include the older drugs like phenytoin, carbamazepine, and valproic acid, and newer agents such as gabapentin, lamotrigine, felbamate, topiramate, vigabatrin, tiagabine, levetiracetam, zonisamide, and oxcarbazepine.